Theseus Pharmaceuticals Inc (THRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 16,403 | 17,587 | 17,055 | 15,479 | 15,948 |
| Operating Income | -16,403 | -17,587 | -17,055 | -15,479 | -15,948 |
| Other Income | 2,899 | 2,782 | 2,469 | 1,762 | 1,203 |
| Pre-tax Income | -13,504 | -14,805 | -14,586 | -13,717 | -14,745 |
| Net Income Continuous | -13,504 | -14,805 | -14,586 | -13,717 | -14,745 |
| Net Income | $-13,504 | $-14,805 | $-14,586 | $-13,717 | $-14,745 |
| EPS Basic Total Ops | -0.31 | -0.34 | -0.34 | -0.36 | -0.38 |
| EPS Basic Continuous Ops | -0.31 | -0.34 | -0.34 | -0.36 | -0.38 |
| EPS Diluted Total Ops | -0.31 | -0.34 | -0.34 | -0.36 | -0.38 |
| EPS Diluted Continuous Ops | -0.31 | -0.34 | -0.34 | -0.36 | -0.38 |
| EPS Diluted Before Non-Recurring Items | -0.31 | -0.34 | -0.34 | -0.35 | -0.38 |
| EBITDA(a) | $-18,115 | $-18,808 | $-17,848 | $-15,892 | $-16,097 |